The TRANSFORM-2 study found patients receiving Spravato were 70% more likely to achieve remission than those on a newly initiated oral antidepressant plus placebo
Spravato Treatment in Missouri City, TX: FDA-Approved Relief for Treatment-Resistant Depression
Find the best Spravato treatment clinic serving Missouri City, TX at Catalyst Health & Wellness — a trusted, REMS-certified Houston provider of the only FDA-approved nasal spray for treatment-resistant depression. Led by Dr. Ho, board-certified anesthesiologist and former pediatrician. Three Houston locations open Monday–Sunday, 5am–9pm.
Begin Again with Spravato Treatment Missouri City
Missouri City wears its accolades well — rated a “Safe, Scenic City” and one of America’s “Best Places to Live,” sitting at the junction of Fort Bend and Harris counties with a diverse, educated community and a quality of life that consistently earns recognition. It’s the kind of city where residents invest in their surroundings and expect their surroundings to invest back. But treatment-resistant depression doesn’t negotiate with quality of life rankings, and when antidepressants fail to deliver — despite the effort, the patience, the adjustment of doses, the switching of medications — that absence of relief can quietly subtract from everything Missouri City offers.
If you’ve been through two or more antidepressants without finding meaningful, lasting improvement, you’re not lacking options. You’re facing a neurobiological situation that requires a different kind of intervention. At Catalyst Health & Wellness, we serve Missouri City residents — and patients from Stafford, Sienna Plantation, Sugar Land, and greater southwest Fort Bend County — as a fully REMS-certified Spravato provider. Spravato (esketamine) is the only FDA-approved nasal spray developed for treatment-resistant depression, and Psychiatric Times Editor in Chief Dr. John J. Miller has called the January 2025 FDA approval of esketamine as a monotherapy “a big win for these depressed patients who have already failed 2 monotherapy oral antidepressant trials.” With Dr. Ho’s clinical expertise, comprehensive insurance support, and a schedule built for Missouri City patients’ demanding lives, Catalyst makes that win accessible.
What is Spravato Therapy?
Spravato (esketamine) earned FDA breakthrough therapy designation before receiving full approval in 2019 — the first new antidepressant mechanism introduced in over 30 years. The FDA extended that approval in 2020 to include adults with major depressive disorder and active suicidal ideation or behaviors. Then, in January 2025, the FDA approved Spravato as a standalone monotherapy for TRD — a milestone that Psychiatric Times described as giving “healthcare providers the freedom to further personalize treatment plans based on individual needs, so patients can experience the efficacy of Spravato in as little as 24 hours, through day 28, without the need for a daily oral antidepressant.”
Research consistently shows powerful results:
What Our Patients Say
Take the First Step Toward Healing
Book Appointment
Conditions We Treat with Spravato Therapy in Missouri City
Spravato holds FDA approval for two specific, well-documented clinical indications — every qualifying Missouri City patient receives a treatment with a comprehensive established evidence record. At Catalyst Health & Wellness, we offer Spravato for:
Your Spravato Therapy Journey at Catalyst Health & Wellness
Every step of the Spravato process at Catalyst has been designed to reduce friction and make treatment genuinely accessible for Missouri City patients. Here's what to expect from first call through long-term care.
Step 1: Free Phone Consultation
Your first call is free and carries no obligation. A clinical team member will discuss your depression history, medication background, and what daily life looks like now. You’ll receive an honest assessment of whether Spravato is the right fit — including a direct answer if it isn’t.
Step 2: Insurance Verification & Prior Authorization
Spravato is often covered by insurance for qualifying patients, but prior authorization is nearly always required. Our team handles it entirely: benefit verification, documentation preparation, prior auth submission, and insurer follow-up until it’s approved. You focus on the decision; we manage the process.
Step 3: Before Your First Visit
Before your appointment, we’ll walk through everything: dietary guidelines, what to bring, transportation logistics, and timing notes for current medications. Nothing about your first session will be unclear when you arrive.
Step 4: Day of Treatment
Plan for approximately two to two-and-a-half hours per visit. You’ll need a designated driver or pre-arranged rideshare — driving on treatment days isn’t permitted. Come comfortable and ready to rest.
Step 5: Your Treatment Session
You’ll settle into a private, purpose-built treatment room — reclinable chair, soft adjustable lighting, warm blankets, noise-cancelling headphones available. Spravato is self-administered as a nasal spray under direct clinical supervision. Dr. Ho’s team monitors your vital signs, blood pressure, and overall response throughout. Temporary effects — mild dissociation, light-headedness — are expected and typically resolve within the two-hour monitoring window.
Step 6: Recovery & Aftercare
After monitoring concludes, you’ll leave with your driver. Driving should wait until the morning after a full night’s sleep. Our team follows up between sessions to track your response and make any adjustments before your next visit.
Step 7: Treatment Schedule & Maintenance
The protocol begins with twice-weekly sessions during weeks one through four, steps to once weekly in weeks five through eight, then transitions to individualized maintenance — weekly, every two weeks, or monthly — based entirely on how you’re responding. Your trajectory guides the schedule.
The Science Behind Spravato for Treatment-Resistant Depression
Spravato’s FDA approval rests on a comprehensive evidence base anchored by two pivotal phase 3 randomized controlled trials, extended by a landmark 2025 monotherapy study, and supported by nearly six years of real-world safety data.
The TRANSFORM-2 study, published in the American Journal of Psychiatry, enrolled patients with confirmed treatment-resistant depression in a double-blind comparison of flexibly-dosed Spravato plus a newly initiated oral antidepressant versus antidepressant plus placebo. Patients receiving Spravato were 70% more likely to achieve remission. Statistically significant improvement was measurable within 24 hours of the first dose — a result that reflects glutamate-driven synaptogenesis beginning in the prefrontal cortex within hours, not the weeks of chemical accumulation that monoamine-targeting medications require.
The SUSTAIN-1 trial, published in JAMA Psychiatry, established that those gains hold. Patients who achieved stable remission or response were randomized to continue Spravato or transition to placebo. Those who continued showed significantly longer time to relapse — a hazard ratio of 0.49 (p=0.003). Psychiatric Times Editor in Chief Dr. John J. Miller has noted that with the 2025 monotherapy approval, esketamine “achieved remission in 15% more patients than placebo at 28 days” — a result that underscores why this treatment represents a genuine clinical advance for patients who’ve exhausted conventional options.
Key research findings:
- Spravato initiates synaptogenesis and neuroplasticity in the prefrontal cortex and mood-regulating brain regions within hours of administration — repair that no monoamine-targeting antidepressant produces
- The ASPIRE I and II trials confirmed significant depressive symptom reduction within 24 hours in patients with MDD and active suicidal ideation — the first FDA-approved rapid pharmacological option for that clinical population
- Real-world data shows a 37–40% remission rate and 48–60% response rate after the first month of Spravato treatment in clinical practice settings
- After three failed oral antidepressants, approximately 86% of TRD patients still don’t achieve remission — underscoring why Spravato’s different mechanism matters clinically, not just theoretically
Why Choose Catalyst Health & Wellness for Spravato Treatment in Missouri City
01
REMS-Certified Provider
The FDA requires all Spravato treatments to occur in a certified healthcare setting under its Risk Evaluation and Mitigation Strategy (REMS) program. Catalyst Health & Wellness holds full REMS certification across all three Houston locations. Missouri City patients receive treatment that meets every federal safety standard, session after session, without exception.
02
Led by Dr. Ho – Expert Medical Care
Dr. Ho’s credentials align precisely with what Spravato treatment requires. His board certification in anesthesiology means deep expertise in esketamine pharmacology, clinical dosing, and the physician-level monitoring that administering an NMDA receptor antagonist in a supervised setting demands. His background as a former pediatrician shapes the culture of the entire clinic — patient-centered, attentive, and focused on how treatment actually feels from your side. Missouri City patients who invest in quality across every domain of their lives deserve that standard from their mental health care.
03
Insurance Navigation Support
Spravato stands apart from most innovative mental health treatments because major commercial insurance plans and Medicare frequently cover it for qualifying patients. Prior authorization is nearly always required, and managing that process on top of depression is a burden patients shouldn’t carry alone. Our team handles it entirely: benefit verification, prior auth submission, insurer follow-up, and appeals when needed. Your energy belongs to healing.
04
Whole-Person Approach
From the first call, we engage with you as a complete person — your full treatment history, your current circumstances, your goals, and what you’re hoping to recover. Treatment plans are shaped by that picture and updated as your response evolves. What this means for you:
- Plans personalized to your specific history and present situation
- Ongoing adjustments based on real response data, not a fixed protocol
- Coordination with your existing psychiatrist or prescribing physician
- Long-term engagement that extends well beyond the induction phase
05
Extended Hours & Flexible Scheduling
Each Spravato session requires two or more hours in clinic. For Missouri City residents managing demanding careers, family responsibilities, and the commute to Houston, fitting a standard weekday clinical window into the schedule is often genuinely impossible. Our 5am to 9pm hours, seven days a week at all three Houston locations, solve that problem. Pre-dawn appointments, evening sessions, weekend treatment — all available. If scheduling has been the reason treatment has been deferred, that barrier is removed.
06
Comprehensive Treatment Options
Spravato is a powerful tool, but it’s not the only one. When your clinical picture benefits from a multi-modal approach, Catalyst offers complementary evidence-based treatments under the same roof:
Ketamine Therapy
Broader applications including anxiety, PTSD, chronic pain, OCD, and bipolar depression
TMS Therapy
Non-invasive magnetic brain stimulation for depression and OCD
Stellate Ganglion Block
Targeted nerve block treatment for PTSD and anxiety
Our goal is to find the right combination of treatments for your unique situation — not to fit you into a one-size-fits-all protocol.
07
Safe, Comfortable Environment
Our treatment rooms were designed specifically for the Spravato experience — not repurposed from other clinical uses. Each is private, quiet, and carefully arranged: reclinable chairs, soft adjustable lighting, warm blankets, noise-cancelling headphones. Dr. Ho’s clinical team is present and monitoring throughout every session. You’re observed, supported, and never alone during treatment.
Getting Started with Spravato Treatment in Missouri City
Missouri City’s commitment to being a safe, scenic, excellent community reflects a city that doesn’t settle for less than its residents deserve. Mental health care should meet that same standard. If treatment-resistant depression has been the area of your life where the best available options have consistently fallen short, Spravato offers a clinically proven, FDA-approved path forward that’s accessible right now.
Call us at 800-772-1242 for your free, no-obligation phone consultation. We’ll discuss your history honestly, answer every question, and give you a clear picture of whether Spravato makes sense for your situation. No charge, no pressure, complete confidentiality.
Three Houston locations serve Missouri City patients, and our 5am to 9pm hours every day of the week mean treatment fits around your life. Dr. Ho and the entire Catalyst team are ready when you are.
Monday-Sunday, 6am-9pm
Free consultation
Insurance assistance
Three Houston locations
REMS-certified provider
Commonly Asked Questions
Get Help NowHow quickly does Spravato therapy work?
Many patients notice improvements within hours or days of their first treatment. The TRANSFORM-2 study showed significant improvement compared to placebo within 24 hours. This rapid action is one of Spravato’s most remarkable qualities, especially compared to traditional antidepressants that can take 4 to 8 weeks to work.
Is Spravato therapy safe?
Yes, when administered by trained medical professionals in a REMS-certified setting. Spravato underwent extensive clinical trials before FDA approval. Common side effects like dissociation, dizziness, and temporary blood pressure increases typically resolve within 1-2 hours. We monitor your vital signs throughout treatment to ensure your safety.
How many treatments will I need?
During the first month, you’ll receive Spravato twice weekly. In the second month, treatment typically decreases to once weekly. After that, most patients continue with maintenance treatments once weekly or every two weeks. The exact frequency depends on your individual response. We’ll work with you to find the schedule that keeps you feeling your best.
What does Spravato treatment feel like?
Experiences vary from person to person. Many patients describe feeling relaxed, calm, or somewhat disconnected from their surroundings. Some people experience mild visual or sensory changes. These effects are temporary and typically resolve within 1-2 hours after treatment ends. Most patients find the experience manageable and therapeutic.
Can I drive after a Spravato treatment?
No, you cannot drive yourself home after Spravato treatment, and you should not drive until the next day after a restful night’s sleep. You’ll need to arrange transportation both to and from your appointment. By the time you leave our facility after the 2-hour observation period, you’ll feel much clearer, but driving remains unsafe until the following day.
Will my insurance cover Spravato?
Many insurance plans cover Spravato for qualifying patients since it’s FDA-approved for treatment-resistant depression. Coverage varies by plan and typically requires prior authorization. Our team handles the insurance process for you, including benefits verification and prior authorization submissions.
Can I continue my current medications?
Spravato is always used alongside an oral antidepressant, so you’ll continue taking your prescribed antidepressant medication. We’ll coordinate with your prescribing physician to ensure your overall treatment plan is optimized. Some medications may require adjustment before starting Spravato, which we’ll discuss during your consultation.
Do I need a referral from my doctor?
No, you don’t need a referral to begin Spravato therapy at Catalyst Health & Wellness. However, coordination with your current prescribing physician is important since Spravato must be used alongside an oral antidepressant. We encourage communication between all members of your healthcare team.
Our Locations
Blog & insight
Insights on Healing, Growth, and Mental Wellness
June 13, 2026
FAQ: Common Questions About Ketamine Treatment Answered
If you've been researching ketamine therapy in Houston, chances are you've come across a lot of conflicting information. One article calls it a miracle cure. Another paints it as a risky party drug. Somewhere in between sits the truth, and you deserve straightforward answers before making any decision about your mental health or chronic pain…
June 10, 2026
Can Ketamine Therapy Help with Both Depression and Anxiety?
If you've spent years battling depression only to find anxiety creeping in alongside it (or vice versa), you're not imagining the connection. These two conditions show up together far more often than people realize, and the overlap can make recovery feel like trying to untangle a knot that keeps tightening. Traditional antidepressants and anti-anxiety medications…
June 7, 2026
Neuropathic Pain and Ketamine: Relief When Nerve Pain Won’t Quit
If you live with neuropathic pain, you already know it doesn't behave like ordinary pain. It burns when nothing touched you. It shocks down your leg while you're sitting still. It turns the brush of a bedsheet into something sharp. And the medications your doctor prescribed, the gabapentin, the duloxetine, maybe even opioids, take the…
Make an Appointment
Our mission is to empower individuals to overcome life’s challenges through professional psychological support.